Latest Ratios: P/E Ratio 5.6x · EV/EBITDA 4.6x · ROE 17.4%. (2022–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Market Cap | $23M | $59M | — | — | — |
| Enterprise Value | $22M | $58M | — | — | — |
| P/E Ratio → | 5.61 | 15.00 | — | — | — |
| P/S Ratio | 0.33 | 0.83 | — | — | — |
| P/B Ratio | 0.80 | 2.15 | — | — | — |
| P/FCF | — | — | — | — | — |
| P/OCF | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| EV / Revenue | — | 0.82 | — | — | — |
| EV / EBITDA | 4.56 | 11.90 | — | — | — |
| EV / EBIT | 4.67 | 12.03 | — | — | — |
| EV / FCF | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Gross Margin | 10.3% | 10.3% | 11.9% | 14.5% | 16.6% |
| Operating Margin | 6.7% | 6.7% | 8.5% | 11.5% | 12.7% |
| Net Profit Margin | 5.6% | 5.6% | 7.8% | 10.0% | 11.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| ROE | 17.4% | 17.4% | 27.3% | 39.8% | 34.0% |
| ROA | 11.7% | 11.7% | 18.8% | 23.6% | 16.1% |
| ROIC | 16.1% | 16.1% | 23.7% | 38.5% | 33.7% |
| ROCE | 19.3% | 19.3% | 27.5% | 41.2% | 32.5% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Debt / Equity | 0.22 | 0.22 | 0.20 | 0.14 | 0.28 |
| Debt / EBITDA | 1.25 | 1.25 | 0.75 | 0.37 | 0.72 |
| Net Debt / Equity | — | -0.03 | -0.03 | -0.09 | -0.14 |
| Net Debt / EBITDA | -0.19 | -0.19 | -0.09 | -0.22 | -0.35 |
| Debt / FCF | — | — | — | -1.24 | -0.54 |
| Interest Coverage | 30.50 | 30.50 | 37.52 | 72.10 | 45.91 |
Net cash position: cash ($7M) exceeds total debt ($6M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Current Ratio | 3.35 | 3.35 | 3.82 | 3.95 | 2.23 |
| Quick Ratio | 3.35 | 3.35 | 3.82 | 3.95 | 2.23 |
| Cash Ratio | 0.59 | 0.59 | 0.89 | 0.97 | 0.46 |
| Asset Turnover | — | 1.74 | 2.10 | 2.37 | 1.45 |
| Inventory Turnover | — | — | — | — | — |
| Days Sales Outstanding | — | 118.44 | 75.05 | 54.76 | 91.11 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Earnings Yield | 17.8% | 6.7% | — | — | — |
| FCF Yield | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $22M | $22M | $22M | $22M |
Working capital liquidity mismatch
According to current market data, YSXT trades at a P/E of 5.83 and a P/S of 0.34, suggesting that investors are heavily discounting the company's future earnings potential due to the persistent disconnect between reported accounting profits and the actual cash generation observed in recent quarterly filings.
The low valuation multiples appear to reflect a market skepticism regarding the durability of the company's thin net margins. Investors should monitor whether these depressed levels represent a value opportunity or a structural recognition of the risks inherent in the company's insurance-linked service aggregation model.
Based on historical financial statements, YSXT's ROIC has trended downward from 11.1% in 2024Q2 to 6.7% in 2026Q2, indicating that the company is struggling to maintain its historical compounding efficiency as it scales its operations within the highly competitive Chinese insurance aftermarket landscape.
The decline in return on invested capital suggests that the marginal cost of acquiring new institutional contracts may be outpacing the incremental returns generated by those services. This trend warrants further investigation into whether the company's expansion strategy is creating long-term shareholder value or merely inflating top-line revenue.
As reported in recent quarterly filings, YSXT's DSO has fluctuated significantly, reaching 66 days in 2026Q2, which highlights a growing reliance on institutional clients for payment and suggests that the company's cash conversion cycle is becoming increasingly strained by its B2B service fulfillment model.
The volatility in receivables collection appears to be a primary driver of the company's deteriorating cash position. Analysts should interpret this as a potential structural weakness, as the company lacks the leverage to enforce tighter payment terms on its larger insurance carrier partners.
Based on the 2026Q2 balance sheet, YSXT's cash position has plummeted to $319.1K, a sharp decline that leaves the company with a precarious liquidity buffer relative to its operational scale and the ongoing working capital demands inherent in its service-aggregation business model.
While the current ratio remains elevated at 3.23, the lack of actual cash on hand suggests that the company's liquidity is tied up in non-liquid current assets. This mismatch may indicate that the company is vulnerable to any sudden disruption in its cash collection cycle.
The most commonly misapplied metric for YSXT is net income, which obscures the company's severe cash flow challenges and fails to account for the significant working capital drag that currently prevents the firm from converting its reported accounting profits into actual, usable liquidity for operations.
Investors should prioritize free cash flow and cash conversion metrics over net income to better understand the company's true financial health. Relying on net income alone may lead to an overly optimistic assessment of the company's ability to sustain its current growth trajectory without external financing.
Includes 30+ ratios · 4 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying YSXT stock.
YSX Tech. Co., Ltd's current P/E ratio is 5.6x. The historical average is 15.0x.
YSX Tech. Co., Ltd's current EV/EBITDA is 4.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.9x.
YSX Tech. Co., Ltd's return on equity (ROE) is 17.4%. The historical average is 29.6%.
Based on historical data, YSX Tech. Co., Ltd is trading at a P/E of 5.6x. Compare with industry peers and growth rates for a complete picture.
YSX Tech. Co., Ltd has 10.3% gross margin and 6.7% operating margin.
YSX Tech. Co., Ltd's Debt/EBITDA ratio is 1.3x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.